We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and Biosimilar Initiative of the Year. Intas & Accord Healthcare also picked up the award for Company of the Year Asia-Pacific.
Accord Healthcare, Intas Pharmaceuticals and Lambda Research were honoured to be shortlisted in a record nine categories at The Global Generics & Biosimilars Awards 2018, which took place on Tuesday the 9th of October in Madrid, Spain.
The Global Generics & Biosimilars Awards reward ‘best practice’ in the two industries, while at the same time encouraging improvements in every aspect of the way business is conducted. Every award effectively underscores the efforts made by the global generics and biosimilars industries to make more affordable medicines available to more people everywhere.
We are truly proud of this success, particularly as it recognises the skill and dedication of the high performing teams throughout our company, and how they make us the award-winners we are today.